标题/作者	年份
The psychology of religion: An empirical approach RW Hood Jr, PC Hill, B Spilka Guilford Publications	2018
ECCO guidelines on therapeutics in Crohn's disease: medical treatment J Torres, S Bonovas, G Doherty, T Kucharzik, JP Gisbert, T Raine, ... Journal of Crohn's and Colitis 14 (1), 4-22	2020
Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry EJ Brenner, RC Ungaro, RB Gearry, GG Kaplan, M Kissous-Hunt, ... Gastroenterology 159 (2), 481-491. e3	2020
2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis MM Ward, A Deodhar, LS Gensler, M Dubreuil, D Yu, MA Khan, N Haroon, ... Arthritis care & research 71 (10), 1285-1299	2019
The microbiome and inflammatory bowel disease KL Glassner, BP Abraham, EMM Quigley Journal of Allergy and Clinical Immunology 145 (1), 16-27	2020
Tumor necrosis factor inhibitors for inflammatory bowel disease OH Nielsen, MA Ainsworth New England Journal of Medicine 369 (8), 754-762	2013
ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment M Adamina, S Bonovas, T Raine, A Spinelli, J Warusavitarne, A Armuzzi, ... Journal of Crohn's and Colitis 14 (2), 155-168	2020
Effect of IBD medications on COVID-19 outcomes: results from an international registry RC Ungaro, EJ Brenner, RB Gearry, GG Kaplan, M Kissous-Hunt, ... Gut 70 (4), 725-732	2021
Anti-TNF therapy in Crohn’s disease SO Adegbola, K Sahnan, J Warusavitarne, A Hart, P Tozer International journal of molecular sciences 19 (8), 2244	2018
Crohn's disease: diagnosis and management B Veauthier, JR Hornecker American family physician 98 (11), 661-669	2018
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 H Nakase, M Uchino, S Shinzaki, M Matsuura, K Matsuoka, T Kobayashi, ... Journal of gastroenterology 56 (6), 489-526	2021
Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study B Zhang, HE Wang, YM Bai, SJ Tsai, TP Su, TJ Chen, YP Wang, ... Gut 70 (1), 85-91	2021
Drugs used in the treatment of gastrointestinal diseases KR McQuaid Basic and clinical pharmacology 10, 1029-35	2018
Acceptance and commitment therapy reduces psychological stress in patients with inflammatory bowel diseases B Wynne, L McHugh, W Gao, D Keegan, K Byrne, C Rowan, K Hartery, ... Gastroenterology 156 (4), 935-945. e1	2019
Efficacy and safety of upadacitinib in a randomized trial of patients with Crohn’s disease WJ Sandborn, BG Feagan, EV Loftus Jr, L Peyrin-Biroulet, G Van Assche, ... Gastroenterology 158 (8), 2123-2138. e8	2020
The role of vitamin D in inflammatory bowel disease: mechanism to management J Fletcher, SC Cooper, S Ghosh, M Hewison Nutrients 11 (5), 1019	2019
The role of early biologic therapy in inflammatory bowel disease DR Berg, JF Colombel, R Ungaro Inflammatory bowel diseases 25 (12), 1896-1905	2019
Management of Crohn disease: a review K Cushing, PDR Higgins Jama 325 (1), 69-80	2021
Targeting cytokine signaling and lymphocyte traffic via small molecules in inflammatory bowel disease: JAK inhibitors and S1PR agonists T Pérez-Jeldres, CJ Tyler, JD Boyer, T Karuppuchamy, A Yarur, DA Giles, ... Frontiers in pharmacology 10, 212	2019
An expert consensus framework for asthma remission as a treatment goal A Menzies-Gow, M Bafadhel, WW Busse, TB Casale, JWH Kocks, ... Journal of Allergy and Clinical Immunology 145 (3), 757-765	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。